Lysergic Acid Diethylamide (LSD) in Palliative Care — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lysergic Acid Diethylamide (LSD) in Palliative Care — Stella

Home/Palliative Care/

View on ClinicalTrials.gov

Recruiting

Back to Palliative Care trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Switzerland

Spital Uster AG, Uster, Canton of Zurich

University Hospital Basel, Basel

University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative Care, Zurich

Key details

Phase

Safety & dosing

Sponsor

University Hospital, Basel, Switzerland

Collaborators

University Hospital, Zürich, Spital Uster AG, Uster, Switzerland

Enrollment target

~60 participants

Started

June 2024

Primary completion

September 2027

Age range

22 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.